Clinical Trial Tests Aquablation Therapy for Prostate Cancer
Dr. Herbert Lepor, a urologic oncologist at NYU Langone’s Perlmutter Cancer Center, leads a study of aquablation therapy for prostate cancer.
Clinical Trial Tests New Treatment for Bladder Cancer
Dr. William C. Huang, a urologic oncologist at NYU Langone’s Perlmutter Cancer Center, is leading a clinical trial for certain bladder cancers.
Clinical Trial Tests Noninvasive Glioblastoma Treatment
Dr. Dimitris G. Placantonakis, a neurosurgeon at NYU Langone’s Perlmutter Cancer Center, is testing a noninvasive treatment for glioblastoma.
Clinical Trial Tests Targeted Treatment for Bladder Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center aims to treat bladder cancer without surgery.
Clinical Trial Tests Therapy for EGFR-Mutant Lung Cancer
Dr. Elaine Shum, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, leads a clinical trial for people with advanced lung cancer.
Clinical Trial to Study Antibody Treatment Against COVID-19
NYU Langone researchers are testing whether an antibody therapy can safely reduce 2019 coronavirus disease (COVID-19) severity.
Clinical Trials Advance Cancer Care
NYU Langone’s Perlmutter Cancer Center is leading the way in providing clinical trials for people with cancer on Long Island.
Clinical Trials Explore New Prostate Cancer Therapies
Researchers at NYU Langone’s Perlmutter Cancer Center are investigating two new treatments for prostate cancer.
Clinical Trials Explore New Treatment for Gynecologic Cancer
Clinical trials at NYU Langone’s Perlmutter Cancer Center are testing antibody–drug conjugates as a treatment for gynecologic cancers.
Clinical Trials Focus on Lung Tumor Immunotherapy Response
NYU Langone pulmonologist Dr. Daniel H. Sterman leads new study to boost lung tumor response rate to immunotherapy.